Last reviewed · How we verify
NCT05987982
Mouth Odor on Preventing Pneumonia by Oral Frailty
NA trial testing Oral exercises and oral hygiene in Breathing, Mouth in 304 participants. Currently enrolling.
31 July 2026
Quick facts
| Lead sponsor | National Cheng-Kung University Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 304 |
| Start date | 14 August 2023 |
| Primary completion | 31 July 2026 |
| Estimated completion | 31 July 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Oral exercises and oral hygiene
- Oral care
Conditions studied
- Breathing, Mouth — all drugs for Breathing, Mouth →
- Pneumonia — all drugs for Pneumonia →
- Frailty — all drugs for Frailty →
Sponsor
National Cheng-Kung University Hospital
Who can join
50 and older, any sex, with Breathing, Mouth or Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research plan aims to first collect data on the oral function and oral hygiene status of the elderly population in the community and to understand the normal model of oral frailty among the older adults in the community. Subsequently, a comparison will be made between the oral status of hospitalized patients and the community-dwelling elderly population. The goal is to verify whether oral odor can be used as an objective biological indicator following intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05987982
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breathing, Mouth
Currently open trials in the same condition.
- NCT06747533 — Impact of Diaphragmatic Breathing Coaching on Deep Inspiration Breath Hold Reproducibility and Organ Protection · NA · active not recruiting
- NCT07411417 — Combined Acupressure Effects on Post-Thoracotomy Pain and Lung Volume · NA · recruiting
- NCT06554353 — Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea · recruiting
- NCT07018128 — Expression of Genes Relating Hypertension and Efficacy of 4-7-8 Breathing Control on Reducing Blood Pressure · NA · recruiting
Other National Cheng-Kung University Hospital trials
Trials by the same sponsor.
- NCT07525713 — Virtual Reality Mirror Therapy With Focused Object-Directed Attention System · NA · not yet recruiting
- NCT07369271 — Continuous Cervical Erector Spinae Plane Block Versus Interscalene Nerve Block in Shoulder Arthroscopic Surgery · NA · not yet recruiting
- NCT07262411 — Peer-based Recovery Program · NA · not yet recruiting
- NCT07257926 — Prevention of Delayed Post-polypectomy Bleeding by Endoscopic Sucralfate Spray in High-risk Patients: A Randomized Contr · Phase 4 · not yet recruiting
- NCT07269132 — Applying the ADDIE Model to Develop a Multimedia Program to Enhance Chemotherapy Knowledge and Self-Efficacy Among Inten · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05987982 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cheng-Kung University Hospital
- Last refreshed: 23 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05987982.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing